ChatGPT Provides Some Helpful Responses for Liver Diseases
FRIDAY, April 28, 2023 (HealthDay News) — ChatGPT provides easy-to-understand information about basic knowledge, lifestyle, and treatments for cirrhosis and liver cancer, according to a study published online March 21 in Clinical and Molecular Hepato…
Learn MoreUna terapia combinada podría prevenir la recurrencia del cáncer tras una cirugía de hígado
LUNES, 24 de abril de 2023 (HealthDay News) — Una terapia combinada de dos medicamentos puede mejorar las probabilidades de supervivencia de las personas con un cáncer de hígado en etapa temprana, a través de unos ataques dirigidos contra las células…
Learn MoreCombo Therapy May Prevent Cancer’s Return After Liver Surgery
MONDAY, April 24, 2023 (HealthDay News) — A two-drug combination therapy can enhance survival odds for people with early-stage liver cancer through targeted attacks on tumor cells, a new clinical trial shows.The combo — atezolizumab (Tecentriq) and …
Learn MoreAACR: Adjuvant Atezolizumab + Bevacizumab Beneficial in Liver Cancer
TUESDAY, April 18, 2023 (HealthDay News) — For patients with high-risk hepatocellular carcinoma (HCC), adjuvant therapy of atezolizumab with bevacizumab (atezo + bev) prolongs recurrence-free survival, according to a study presented at the annual mee…
Learn MoreFighting Liver Cancer Takes Big Financial Toll: Study
THURSDAY, Feb. 2, 2023 (HealthDay News) — Out-of-pocket costs can leave Medicare patients with the most common type of liver cancer in financial distress.While Medicare payments in the first year after diagnosis with hepatocellular carcinoma (HCC) ex…
Learn MoreRobotic Resection Cuts Perioperative Morbidity With Liver Cancer
MONDAY, Nov. 28, 2022 (HealthDay News) — Robotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), according to a study publi…
Learn MoreLiver Cancer in Top Five Causes of Cancer Deaths in 90 Countries
THURSDAY, Oct. 13, 2022 (HealthDay News) — Liver cancer is a major cause of death in many countries, according to a study published online Oct. 5 in the Journal of Hepatology.Harriet Rumgay, from the International Agency for Research on Cancer in Lyo…
Learn MoreLiver Cancer Risk May Rise for 2nd-, 3rd-Generation U.S. Mexicans
TUESDAY, Sept. 20, 2022 (HealthDay News) — The risk of hepatocellular carcinoma (HCC) appears to be increased for successive generations of U.S. Mexicans, according to a study presented at the 15th AACR Conference on the Science of Cancer Health Disp…
Learn MoreLa infección con la hepatitis C puede matar, pero menos de un tercio de los pacientes se tratan
MIÉRCOLES, 10 de agosto de 2022 (HealthDay News) — Menos de un tercio de las personas con hepatitis C reciben tratamiento para esta infección, que es potencialmente letal, pero curable, en un plazo de un año tras su diagnóstico, advierte un nuevo inf…
Learn MoreVinculan a las PFAS, unos ‘compuestos permanentes’, con el cáncer de hígado
MIÉRCOLES, 10 de agosto de 2022 (HealthDay News) — Un compuesto llamado sulfato de perfluooctano (PFOS) se ha vinculado con el tipo más común de cáncer de hígado, indica un estudio reciente.El PFOS se utiliza en una amplia variedad de productos del c…
Learn More